Healthcare & Medical Devices Global On demand · 24-48h

Global Disposable Hemoperfusion Market Strategic Research Report

Global Disposable Hemoperfusion Market Strategic Research Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Disposable Hemoperfusion Market
$1.52B2025
12.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Charcoal Hemoperfusion, Certain Resins Hemoperfusion

By Application: Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Baxter International, Asahi Kasei Corporation, CytoSorbentsCompany 11, Kaneka Pharma, Toray Medical, Aier, Tianjin Zibo High Technology, Biosun Corporation, Kangbei Medical Device, Jafron Biomedical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 103 pages
Market size 2025
$1.52B
Billion USD
Forecast CAGR
12.7%
2025-2032
Forecast 2032
$3.5B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Disposable Hemoperfusion market size is predicted to grow from US$ 1,517 million in 2025 to US$ 3,472 million in 2032; it is expected to grow at a CAGR of 12.7% from 2026 to 2032.

Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient"s body. In this report, we calculate medical consumables of hemoperfusion.

China is the largest market with about 48% market share. Followed by Europe and Japan, accounting for about 35% market share.

The key players are Baxter International, Asahi Kasei Corporation, CytoSorbentsCompany 11, Kaneka Pharma, Toray Medical, Aier, Tianjin Zibo High Technology, Biosun Corporation, Kangbei Medical Device, Jafron Biomedical etc. Top 3 companies occupied about 64% revenue market share.

This report presents a comprehensive overview of the global Disposable Hemoperfusion market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Charcoal Hemoperfusion
  • Certain Resins Hemoperfusion

Segment by Application

  • Overdose
  • Specific Intoxications
  • Certain Autoimmune Diseases
  • Hepatic Encephalopathy
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Disposable Hemoperfusion market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Overdose, Specific Intoxications, Certain Autoimmune Diseases evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Disposable Hemoperfusion Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.52B
2025
Forecast
$3.5B
2032
CAGR
12.7%
2025–2032
Regiões
5
global
Key companies
Baxter InternationalAsahi Kasei CorporationCytoSorbentsCompany 11Kaneka PharmaToray MedicalAierTianjin Zibo High TechnologyBiosun Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Charcoal HemoperfusionCertain Resins Hemoperfusion
By Application
OverdoseSpecific IntoxicationsCertain Autoimmune DiseasesHepatic EncephalopathyOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Charcoal Hemoperfusion
  • 3.1.3 Certain Resins Hemoperfusion
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Overdose
  • 4.1.3 Specific Intoxications
  • 4.1.4 Certain Autoimmune Diseases
  • 4.1.5 Hepatic Encephalopathy
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Baxter International
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Asahi Kasei Corporation
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 CytoSorbentsCompany 11
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Kaneka Pharma
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Toray Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Aier
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Tianjin Zibo High Technology
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Biosun Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Kangbei Medical Device
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Jafron Biomedical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Disposable Hemoperfusion market?
The global Disposable Hemoperfusion market is estimated at US$ 1.52 billion in 2025 (base year) and is projected to reach US$ 3.47 billion by 2032.
What is the forecast CAGR for the Disposable Hemoperfusion market?
The market is expected to grow at a CAGR of 12.7% from 2026 to 2032, expanding from US$ 1.52 billion in 2025 to US$ 3.47 billion in 2032, roughly 2.3 times its base-year value.
What is Disposable Hemoperfusion?
Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
What are the main segments of the Disposable Hemoperfusion market by type?
By type, the market is segmented into Charcoal Hemoperfusion and Certain Resins Hemoperfusion.
Which applications drive demand in the Disposable Hemoperfusion market?
Key applications covered include Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy and Others.
Who are the key players in the Disposable Hemoperfusion market?
Key players profiled include Baxter International, Asahi Kasei Corporation, CytoSorbentsCompany 11, Kaneka Pharma, Toray Medical, Aier, Tianjin Zibo High Technology and Biosun Corporation, among 10 companies covered in total.
Which regions and countries are covered for Disposable Hemoperfusion?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Disposable Hemoperfusion market report?
The report is intended for manufacturers and solution providers, distributors and end users in Overdose, Specific Intoxications and Certain Autoimmune Diseases, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Disposable Hemoperfusion market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.